- Economic and Clinical Benefits of Galantamine in the Treatment of Mild to Moderate Alzheimer's Disease in a Korean Population: A 52-Week Prospective Study
-
Suh GH, Jung HY, Lee CU, Choi S, Korean Galantamine Study Group
- KMID: 1786838
- J Korean Med Sci.
- 2008 Feb;23(1):10-17.
- doi: 10.3346/jkms.2008.23.1.10
To evaluate the impact of galantamine treatment on the function, caregiver time, and resource used in the treatment of patients with mild to moderate Alzheimer's disease (AD), costs and outcomes... -
- CITED
-
- Close
- SHARE
-
- Close
